Factor V Leiden in patients with venous thrombosis in Slovak population

被引:0
|
作者
Simkova, M
Batorova, A
Dostalova, K
Pozgayova, S
Simko, F
Kovacs, L
机构
[1] Comenius Univ, Sch Med, Dept Pediat 1, Bratislava 83340, Slovakia
[2] Univ Hosp, Clin Haematol & Tranfus, Bratislava, Slovakia
[3] Comenius Univ, Sch Med, Dept Internal Med 3, Bratislava 83340, Slovakia
[4] Comenius Univ, Sch Med, Dept Pediat 2, Bratislava 83340, Slovakia
[5] Comenius Univ, Sch Med, Dept Pathophysiol, Bratislava 83340, Slovakia
关键词
venous thrombosis; thromboembolic disease; APCR; factor V Leiden prevalence;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Resistance to activated protein C determined by factor V Leiden (FVL) is the most frequent inherited risk factor of venous thrombosis. The purpose of our work was to reveal the frequency of FVL in Slovak patients with venous thromboses, to characterise the nature of venous thromboses in this inherited thrombophilia, and to consider the screening approach to investigation of FVL in patients with venous thromboses. 350 patients with a diagnosis of venous thromboembolic disease from various regions of Slovakia were investigated. FVL, detected by polymerase chain reaction, was found in 128/350 (37%) patients with venous thromboses. 118/128 (92%) patients were heterozygous and 10/128 (8%) were homozygous carriers. In 108/128 (84%) patients with FVL the thromboembolic disease occurred spontaneously. Phlebothrombosis occurred predominantly in the lower limbs 117/128 (91%) patients, atypical localisations were rare. The first thromboembolic event was manifested before 40 years of age in 69% of patients. The family history was positive in 60/128 (47%) FVL carriers with thromboembolic disease. Recurrent thrombosis occurred in 30% of patients with FVL. In agreement with findings in other European countries, the prevalence of FVL was high in Slovak patients with thromboembolic disease. The investigation of FVL seems to be justified in patients before. 40 years of age with venous thrombosis of lower limbs, in the absence of triggering factors and with a family history of venous thromboembolic disease.
引用
收藏
页码:435 / 442
页数:8
相关论文
共 50 条
  • [21] FACTOR-V LEIDEN IS NOT A PREDICTIVE PARAMETER FOR RECURRENT THROMBOSIS IN PATIENTS (PTS) WITH A HISTORY OF VENOUS THROMBOSIS (VT)
    RINTELEN, C
    KNOBL, P
    OVISSI, L
    PABINGER, I
    MANNHALTER, C
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1371 - 1371
  • [22] Factor V Leiden in Mexican Pediatric Patients With Thrombosis
    Parra-Ortega, Israel
    Sanchez-Huerta, Jose Luis
    Lopez-Martinez, Briceida
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2009, 15 (04) : 477 - 477
  • [23] The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease
    Liebman, HA
    Ashani, N
    Sutherland, D
    McGehee, W
    Kam, L
    GASTROENTEROLOGY, 1998, 115 (04) : 830 - 834
  • [24] Prevalence of factor V Leiden in patients with venous thrombosis at a major referral center for thrombotic conditions
    Liles, D
    Thomas, D
    Sallah, S
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1259 - P1259
  • [25] Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients
    Kennedy, M
    Andreescu, ACM
    Greenblatt, MS
    Jiang, HY
    Thomas, CA
    Chassereau, L
    Wong, C
    Durda, P
    Cushman, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (03) : 386 - 388
  • [26] High Prevalence of Activated Protein C Resistance and Factor V Leiden Mutation in an Arab Population and Patients With Venous Thrombosis in Kuwait
    Jadaon, Mehrez M.
    Dashti, Ali A.
    Lewis, Hend L.
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2010, 19 (03) : 180 - 183
  • [27] Factor V Leiden prevalence in venous thromboembolism patients
    Leroyer, C
    Mercier, B
    Escoffre, M
    Ferec, C
    Mottier, D
    CHEST, 1997, 111 (06) : 1603 - 1606
  • [28] Is travelling a risk factor for venous thrombosis in individuals with factor V Leiden in heterozygous form?
    Dulícek, P
    Maly, J
    Beránek, M
    34th Hemophilia Symposium, 2005, : 272 - 274
  • [29] Venous thrombosis and the incidence of factor V Leiden and factor II A20210 mutation in the cardiac pacing patients
    Domagala, T. B.
    Lelakowski, J.
    Janczura, M.
    Dziedzina, S.
    Iwaniec, T.
    Rydlewska, A.
    Musial, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1108 - 1108
  • [30] Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis
    van Dunné, FM
    Doggen, CJM
    Heemskerk, M
    Rosendaal, FR
    Helmerhorst, FM
    HUMAN REPRODUCTION, 2005, 20 (03) : 802 - 806